Company: BOLT
Filing Date: 2025-03-24
Form Type: 10-K
Source: 0000950170-25-043873
Chunk: 2

Company: Bolt Biotherapeutics, Inc.
Filing Date: 2025-03-24
Form: 10-K
Item: Item 12
Chunk 2
---
The information required by this Item will be set forth in our definitive proxy statement to be filed with the Securities and Exchange Commission within 120 days after our fiscal year ended December 31, 2024 under the caption “Security Ownership of Certain Beneficial Owners and Management” and is incorporated herein by reference.

Information regarding our equity compensation plans required by this item will be set forth in our definitive proxy statement to be filed with the Securities and Exchange Commission within 120 days after our fiscal year ended December 31, 2024 under the caption "Equity Compensation Plan Information," and is incorporated by reference.